Home » Topics » BioWorld Science

BioWorld Science
RSS

Jasan Bio Medicine (Jiaxing) synthesizes new DHFR inhibitors

Aug. 17, 2021

Chinese researchers divulge new PD-1/PD-L1 interaction inhibitors

Aug. 17, 2021

Chengdu Biobel patents compounds for C. difficile infection

Aug. 17, 2021

Moderna initiates phase I/II study of mRNA-3705 for methylmalonic acidemia

Aug. 17, 2021

Phase II study initiated to assess aspacytarabine in AML and MDS patients

Aug. 17, 2021

Aberrant NAD+ metabolism underlies Zika microcephaly

Aug. 17, 2021

FDA lifts clinical hold on trial of Danon disease treatment RP-A501

Aug. 16, 2021

LAVA Therapeutics cleared to initiate clinical trial of LAVA-1207

Aug. 16, 2021

Enanta's HBV treatment begins phase I study

Aug. 16, 2021

Leptin linked to severity of COVID-19

Aug. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...